Source: Eur Respir J 2002; 20: 1102-1109
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Zhang J., Yu C., Holgate S.T., Reiss T.F.. Variability and lack of predictive ability of asthma end-points in clinical trials. Eur Respir J 2002; 20: 1102-1109

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma Source: International Congress 2018 – Tests and trends in asthma Year: 2018 ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Correlation of airway obstruction and patient-reported endpoints in clinical studies Source: Eur Respir J 2001; 17: 220-224 Year: 2001 Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019 Year: 2019 Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007 Methacoline challenge response in controlled asthma and correlations with other disease characteristics Source: Annual Congress 2012 - Asthma management Year: 2012 Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Clustering of adherence variability metrics and clinical outcomes in asthma Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017 Prevalence of altering selected spirometry maneuvers in asthma clinical trials. Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study Source: International Congress 2017 – Monitoring asthma control Year: 2017 Short-term and long-term reproducibility of non-invasive clinical and inflammatory parameters in asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 The ability of fluctuation analysis of airway function and symptoms to asses asthma stability in different asthma phenotypes Source: Eur Respir J 2007; 30: Suppl. 51, 257s Year: 2007 Can we predict response of refractory asthmatic cough to tiotropium? :a prospective study Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020